Bausch + Lomb (BLCO) News Today → [Webinar] A Deep Dive into Options Volatility: Skew & Relative Value (From OIC) (Ad) Free BLCO Stock Alerts $15.30 +0.01 (+0.07%) (As of 09:39 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMorgan Stanley Upgrades Bausch + Lomb (NYSE:BLCO) to Overweightamericanbankingnews.com - May 8 at 3:16 AMMorgan Stanley Upgrades Bausch + Lomb (BLCO)msn.com - May 7 at 10:55 AMBausch + Lomb (NYSE:BLCO) Shares Gap Up to $13.60marketbeat.com - May 6 at 5:33 PMMorgan Stanley upgrades Bausch + Lomb, cites improving marginsmsn.com - May 6 at 2:52 PMBausch + Lomb (NYSE:BLCO) Upgraded to Overweight at Morgan Stanleymarketbeat.com - May 6 at 8:28 AMBausch + Lomb (NYSE:BLCO) Given "Buy" Rating at HC Wainwrightamericanbankingnews.com - May 6 at 4:14 AMBausch + Lomb Co. Forecasted to Post Q4 2024 Earnings of $0.36 Per Share (NYSE:BLCO)americanbankingnews.com - May 6 at 3:34 AMBausch & Lomb: Top 10 Undervalued Growth Stocks on TSX (BLCO)theglobeandmail.com - May 4 at 4:34 PMBausch + Lomb (NYSE:BLCO) Price Target Cut to $15.00americanbankingnews.com - May 4 at 6:20 AMBausch + Lomb Co. to Post Q2 2024 Earnings of $0.20 Per Share, HC Wainwright Forecasts (NYSE:BLCO)americanbankingnews.com - May 4 at 2:02 AMQ2 2024 Earnings Forecast for Bausch + Lomb Co. Issued By HC Wainwright (NYSE:BLCO)marketbeat.com - May 3 at 8:40 AMBausch + Lomb First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lagsfinance.yahoo.com - May 3 at 8:26 AMBausch + Lomb (NYSE:BLCO) Stock Rating Reaffirmed by Needham & Company LLCamericanbankingnews.com - May 3 at 5:18 AMBausch + Lomb recalls Project Watson dog eye wipes due to risk of bacteria, fungus exposuremsn.com - May 3 at 2:35 AMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), 10x Genomics (TXG) and LivaNova (LIVN)markets.businessinsider.com - May 3 at 2:35 AMBausch + Lomb (NYSE:BLCO) Reaches New 1-Year Low on Disappointing Earningsamericanbankingnews.com - May 3 at 1:46 AMRobust Start and Organic Growth Affirm Bausch + Lomb’s Buy Ratingmarkets.businessinsider.com - May 2 at 4:33 PMBuy Rating Affirmed for Bausch + Lomb: Strong Q1 Performance and Promising Growth Outlook Despite FX Headwindsmarkets.businessinsider.com - May 2 at 4:33 PMBausch + Lomb (NYSE:BLCO) PT Lowered to $15.00 at Evercoremarketbeat.com - May 2 at 2:31 PMBausch + Lomb (NYSE:BLCO) Hits New 1-Year Low After Earnings Missmarketbeat.com - May 2 at 12:45 PMBausch + Lomb (NYSE:BLCO) Posts Earnings Results, Misses Expectations By $0.02 EPSmarketbeat.com - May 2 at 12:07 PMBausch + Lomb (NYSE:BLCO) Stock Rating Reaffirmed by HC Wainwrightmarketbeat.com - May 2 at 8:35 AMQ1 2024 Bausch + Lomb Corp Earnings Call Transcriptgurufocus.com - May 2 at 1:01 AMBausch + Lomb Quarterly Loss Widensmarketwatch.com - May 1 at 9:39 AMBausch + Lomb Announces First-Quarter 2024 Resultsbusinesswire.com - May 1 at 6:58 AMShort Interest in Bausch + Lomb Co. (NYSE:BLCO) Expands By 8.7%marketbeat.com - April 30 at 6:47 PMBausch + Lomb Q1 2024 Earnings Previewmsn.com - April 30 at 3:34 PMBausch + Lomb Co. (NYSE:BLCO) Given Consensus Recommendation of "Moderate Buy" by Analystsamericanbankingnews.com - April 30 at 2:18 AMBausch + Lomb Co. (NYSE:BLCO) Given Consensus Recommendation of "Moderate Buy" by Brokeragesmarketbeat.com - April 30 at 2:17 AMBausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meetingbusinesswire.com - April 29 at 7:00 AMBausch + Lomb reports positive study results for Blink NutriTearsmsn.com - April 25 at 2:19 PMBausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyesbusinesswire.com - April 25 at 8:30 AMAnalysts Are Bullish on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), Edgewise Therapeutics (EWTX)markets.businessinsider.com - April 22 at 4:11 PMRoyal Bank of Canada Cuts Bausch + Lomb (NYSE:BLCO) Price Target to $18.00marketbeat.com - April 22 at 12:12 PMBausch + Lomb Corporation (BLCO)finance.yahoo.com - April 18 at 1:42 PMBausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programsbusinesswire.com - April 18 at 7:00 AMBausch + Lomb Co. (NYSE:BLCO) Shares Purchased by River Road Asset Management LLCmarketbeat.com - April 17 at 4:41 PMBausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1businesswire.com - April 15 at 12:00 PMBausch Health gains after appeals court affirms ruling in Norwich patent case (update)msn.com - April 11 at 3:26 PMBausch + Lomb (NYSE:BLCO) Sees Unusually-High Trading Volumemarketbeat.com - April 11 at 2:49 PMBausch + Lomb’s Strong Market Position and Innovative Pipeline Justify Buy Ratingmarkets.businessinsider.com - April 9 at 3:37 PMBausch + Lomb (NYSE:BLCO) PT Raised to $17.00 at Evercore ISImarketbeat.com - April 4 at 12:44 PMBausch + Lomb’s Strong Position in Dry Eye Market Prompts Buy Ratingmarkets.businessinsider.com - April 2 at 1:44 PMShort Interest in Bausch + Lomb Co. (NYSE:BLCO) Decreases By 20.1%marketbeat.com - March 30 at 4:44 PMBLCO Crosses Above Key Moving Average Levelnasdaq.com - March 29 at 10:53 AMBLCO Apr 2024 17.500 callfinance.yahoo.com - March 16 at 9:52 AMBausch + Lomb Co. (NYSE:BLCO) Receives Average Recommendation of "Moderate Buy" from Analystsmarketbeat.com - March 11 at 2:15 AMBenchmark upgrades Emergent Biosolutions to Buymsn.com - March 7 at 12:16 PMLaurion Capital Management LP Lowers Holdings in Bausch + Lomb Co. (NYSE:BLCO)marketbeat.com - March 4 at 1:35 PMBausch + Lomb Co. (NYSE:BLCO) Shares Bought by Alberta Investment Management Corpmarketbeat.com - March 1 at 4:23 PM Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Email Address The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide BLCO Media Mentions By Week BLCO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLCO News Sentiment▼0.400.45▲Average Medical News Sentiment BLCO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLCO Articles This Week▼164▲BLCO Articles Average Week Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RxSight News Today STAAR Surgical News Today National Vision News Today Cooper Companies News Today Halozyme Therapeutics News Today Organon & Co. News Today Lantheus News Today Option Care Health News Today BridgeBio Pharma News Today Apellis Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BLCO) was last updated on 5/10/2024 by MarketBeat.com Staff From Our Partners[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICYou need to know these two things about AI stocks ASAP…InvestorPlaceThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressCharles Payne Demystifies OptionsUnstoppable Prosperity[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch + Lomb Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
